ARCHIVES

FDA Can’t Prohibit Distribution of Articles, Books On Off-Label Drug Use, Judge Rules

This article is from The Cancer Letter archive.

Vol. 25 No. 32 | August 13, 1999

Download PDF Visit The Full Archive

Related Articles

Aranesp Improved Anemia In MDS In Phase II Trial

September 30, 2005

Blinatumomab Demonstrates High Response Rate in ALL

June 29, 2012

Reinventing NCI: Clinical Trials System Changes Not Easy Or Quick, Klausner Says; NCAB Members, Others, Sound Off On Group’s Report

October 10, 1997

In Brief: Carcinogenesis Task Force to Wrap Up Review In Four-Six Weeks; UCLA Groundbreaking Set

October 28, 1977

Pretreatment with Azacitidine Achieves 28-Month Remission

August 30, 2013

Final Issue Of 1992

December 11, 1992